Heterogeneity in Drug Recommendation Compliance: Evidence from France of a Gender Bias in the Treatment of Alzheimer’s Patients
Heterogeneity in Drug Recommendation Compliance: Evidence from France of a Gender Bias in the Treatment of Alzheimer’s Patients
12 mai 2020 Aucun commentaire sur Heterogeneity in Drug Recommendation Compliance: Evidence from France of a Gender Bias in the Treatment of Alzheimer’s PatientsChauvin, P, Bellanger, M, Rapp, T., Sirven N (2020). Heterogeneity in Drug Recommendation Compliance: Evidence from France of a Gender Bias in the Treatment of Alzheimer’s Patients. Forthcoming in Journal de gestion et d’économie de la santé. (CNRS rang 4).
